nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranexamic Acid—PLG—Dissolution of Fibrin Clot—SERPINE2—chronic obstructive pulmonary disease	0.0407	0.0944	CbGpPWpGaD
Tranexamic Acid—PLG—Activation of Matrix Metalloproteinases—ELANE—chronic obstructive pulmonary disease	0.0243	0.0563	CbGpPWpGaD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—ELANE—chronic obstructive pulmonary disease	0.0195	0.0453	CbGpPWpGaD
Tranexamic Acid—PLG—respiratory system—chronic obstructive pulmonary disease	0.0168	0.238	CbGeAlD
Tranexamic Acid—PLG—connective tissue—chronic obstructive pulmonary disease	0.0148	0.209	CbGeAlD
Tranexamic Acid—PLG—Dissolution of Fibrin Clot—PLAUR—chronic obstructive pulmonary disease	0.0143	0.0332	CbGpPWpGaD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP12—chronic obstructive pulmonary disease	0.0139	0.0323	CbGpPWpGaD
Tranexamic Acid—PLG—smooth muscle tissue—chronic obstructive pulmonary disease	0.0136	0.191	CbGeAlD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—ELANE—chronic obstructive pulmonary disease	0.0107	0.0249	CbGpPWpGaD
Tranexamic Acid—PLG—Activation of Matrix Metalloproteinases—MMP14—chronic obstructive pulmonary disease	0.0106	0.0245	CbGpPWpGaD
Tranexamic Acid—PLG—Dissolution of Fibrin Clot—PLAU—chronic obstructive pulmonary disease	0.01	0.0233	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—SOD3—chronic obstructive pulmonary disease	0.0096	0.0223	CbGpPWpGaD
Tranexamic Acid—PLG—lung—chronic obstructive pulmonary disease	0.00894	0.126	CbGeAlD
Tranexamic Acid—PLG—amb2 Integrin signaling—CTGF—chronic obstructive pulmonary disease	0.00829	0.0192	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—SOD3—chronic obstructive pulmonary disease	0.00781	0.0181	CbGpPWpGaD
Tranexamic Acid—PLG—Dissolution of Fibrin Clot—SERPINE1—chronic obstructive pulmonary disease	0.00777	0.018	CbGpPWpGaD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—MMP12—chronic obstructive pulmonary disease	0.00763	0.0177	CbGpPWpGaD
Tranexamic Acid—PLG—Regulation of IGF Activity by IGFBP—MMP1—chronic obstructive pulmonary disease	0.00697	0.0162	CbGpPWpGaD
Tranexamic Acid—PLG—amb2 Integrin signaling—PLAUR—chronic obstructive pulmonary disease	0.00696	0.0162	CbGpPWpGaD
Tranexamic Acid—PLG—Blood Clotting Cascade—PLAU—chronic obstructive pulmonary disease	0.00659	0.0153	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—MPO—chronic obstructive pulmonary disease	0.00645	0.015	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.00621	0.0144	CbGpPWpGaD
Tranexamic Acid—PLG—Complement and Coagulation Cascades—SERPINA1—chronic obstructive pulmonary disease	0.00609	0.0141	CbGpPWpGaD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—PLAUR—chronic obstructive pulmonary disease	0.0056	0.013	CbGpPWpGaD
Tranexamic Acid—SLC15A2—respiratory system—chronic obstructive pulmonary disease	0.00538	0.0761	CbGeAlD
Tranexamic Acid—PLG—Folate Metabolism—MPO—chronic obstructive pulmonary disease	0.00524	0.0122	CbGpPWpGaD
Tranexamic Acid—PLG—Blood Clotting Cascade—SERPINE1—chronic obstructive pulmonary disease	0.0051	0.0118	CbGpPWpGaD
Tranexamic Acid—PLG—Activation of Matrix Metalloproteinases—MMP1—chronic obstructive pulmonary disease	0.00498	0.0116	CbGpPWpGaD
Tranexamic Acid—PLG—amb2 Integrin signaling—PLAU—chronic obstructive pulmonary disease	0.00489	0.0113	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—SERPINA1—chronic obstructive pulmonary disease	0.00477	0.0111	CbGpPWpGaD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—MMP14—chronic obstructive pulmonary disease	0.00466	0.0108	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—SERPINA1—chronic obstructive pulmonary disease	0.00455	0.0106	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—ELANE—chronic obstructive pulmonary disease	0.00449	0.0104	CbGpPWpGaD
Tranexamic Acid—SLC15A2—bronchus—chronic obstructive pulmonary disease	0.00443	0.0626	CbGeAlD
Tranexamic Acid—PLG—Complement and Coagulation Cascades—PLAUR—chronic obstructive pulmonary disease	0.00427	0.00991	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.00417	0.00967	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—TGFB2—chronic obstructive pulmonary disease	0.00414	0.0096	CbGpPWpGaD
Tranexamic Acid—SLC15A2—trachea—chronic obstructive pulmonary disease	0.00398	0.0562	CbGeAlD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—TGFB2—chronic obstructive pulmonary disease	0.00394	0.00915	CbGpPWpGaD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—PLAU—chronic obstructive pulmonary disease	0.00393	0.00912	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.00369	0.00855	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—CRP—chronic obstructive pulmonary disease	0.00339	0.00787	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP12—chronic obstructive pulmonary disease	0.0032	0.00742	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—ELN—chronic obstructive pulmonary disease	0.0032	0.00742	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00305	0.00707	CbGpPWpGaD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SERPINE1—chronic obstructive pulmonary disease	0.00304	0.00706	CbGpPWpGaD
Tranexamic Acid—PLG—Complement and Coagulation Cascades—PLAU—chronic obstructive pulmonary disease	0.00299	0.00695	CbGpPWpGaD
Tranexamic Acid—PLG—amb2 Integrin signaling—MMP9—chronic obstructive pulmonary disease	0.00289	0.00672	CbGpPWpGaD
Tranexamic Acid—PLG—Syndecan-4-mediated signaling events—MMP9—chronic obstructive pulmonary disease	0.00289	0.00672	CbGpPWpGaD
Tranexamic Acid—PLG—Activation of Matrix Metalloproteinases—MMP9—chronic obstructive pulmonary disease	0.00289	0.00672	CbGpPWpGaD
Tranexamic Acid—SLC15A2—lung—chronic obstructive pulmonary disease	0.00286	0.0404	CbGeAlD
Tranexamic Acid—PLG—Folate Metabolism—CRP—chronic obstructive pulmonary disease	0.00276	0.0064	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00271	0.0063	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.0026	0.00604	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—ALB—chronic obstructive pulmonary disease	0.0026	0.00603	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—NOS3—chronic obstructive pulmonary disease	0.00252	0.00586	CbGpPWpGaD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—chronic obstructive pulmonary disease	0.00233	0.00541	CbGpPWpGaD
Tranexamic Acid—PLG—Complement and Coagulation Cascades—SERPINE1—chronic obstructive pulmonary disease	0.00232	0.00538	CbGpPWpGaD
Tranexamic Acid—Atrial fibrillation—Formoterol—chronic obstructive pulmonary disease	0.00223	0.00447	CcSEcCtD
Tranexamic Acid—PLG—amb2 Integrin signaling—TNF—chronic obstructive pulmonary disease	0.00223	0.00517	CbGpPWpGaD
Tranexamic Acid—Angina pectoris—Tiotropium—chronic obstructive pulmonary disease	0.0022	0.00442	CcSEcCtD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—MMP1—chronic obstructive pulmonary disease	0.0022	0.0051	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.00219	0.00509	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.00217	0.00504	CbGpPWpGaD
Tranexamic Acid—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.00213	0.00428	CcSEcCtD
Tranexamic Acid—Dermatitis atopic—Prednisolone—chronic obstructive pulmonary disease	0.00213	0.00427	CcSEcCtD
Tranexamic Acid—PLG—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.00212	0.00492	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	0.00212	0.00491	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	0.00211	0.00491	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—ALB—chronic obstructive pulmonary disease	0.00211	0.00491	CbGpPWpGaD
Tranexamic Acid—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00211	0.00423	CcSEcCtD
Tranexamic Acid—Atrial fibrillation—Salbutamol—chronic obstructive pulmonary disease	0.00211	0.00422	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00201	0.00403	CcSEcCtD
Tranexamic Acid—Renal failure—Tiotropium—chronic obstructive pulmonary disease	0.00198	0.00398	CcSEcCtD
Tranexamic Acid—Migraine—Salbutamol—chronic obstructive pulmonary disease	0.00196	0.00394	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP14—chronic obstructive pulmonary disease	0.00195	0.00453	CbGpPWpGaD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—chronic obstructive pulmonary disease	0.00192	0.00445	CbGpPWpGaD
Tranexamic Acid—Cramp muscle—Formoterol—chronic obstructive pulmonary disease	0.0019	0.00382	CcSEcCtD
Tranexamic Acid—Cramp muscle—Arformoterol—chronic obstructive pulmonary disease	0.0019	0.00382	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.0019	0.00441	CbGpPWpGaD
Tranexamic Acid—Sinusitis—Tiotropium—chronic obstructive pulmonary disease	0.00189	0.0038	CcSEcCtD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—chronic obstructive pulmonary disease	0.00188	0.00437	CbGpPWpGaD
Tranexamic Acid—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00186	0.00374	CcSEcCtD
Tranexamic Acid—Cramp muscle—Montelukast—chronic obstructive pulmonary disease	0.00186	0.00374	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.00184	0.00426	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	0.00182	0.00421	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—ALB—chronic obstructive pulmonary disease	0.00181	0.00421	CbGpPWpGaD
Tranexamic Acid—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.0018	0.00361	CcSEcCtD
Tranexamic Acid—PLG—amb2 Integrin signaling—IL6—chronic obstructive pulmonary disease	0.0018	0.00417	CbGpPWpGaD
Tranexamic Acid—Cramp muscle—Salbutamol—chronic obstructive pulmonary disease	0.0018	0.0036	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—KL—chronic obstructive pulmonary disease	0.00179	0.00415	CbGpPWpGaD
Tranexamic Acid—Embolism—Prednisone—chronic obstructive pulmonary disease	0.00178	0.00358	CcSEcCtD
Tranexamic Acid—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.00178	0.00358	CcSEcCtD
Tranexamic Acid—Angina pectoris—Formoterol—chronic obstructive pulmonary disease	0.00178	0.00357	CcSEcCtD
Tranexamic Acid—Angina pectoris—Arformoterol—chronic obstructive pulmonary disease	0.00178	0.00357	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00177	0.00354	CcSEcCtD
Tranexamic Acid—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00176	0.00354	CcSEcCtD
Tranexamic Acid—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.00175	0.0035	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00174	0.00403	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	0.00173	0.00401	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—ALB—chronic obstructive pulmonary disease	0.00173	0.00401	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	0.00172	0.00399	CbGpPWpGaD
Tranexamic Acid—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.00172	0.00344	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.00171	0.00397	CbGpPWpGaD
Tranexamic Acid—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.00169	0.0034	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00169	0.00338	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.00168	0.0039	CbGpPWpGaD
Tranexamic Acid—Angina pectoris—Salbutamol—chronic obstructive pulmonary disease	0.00168	0.00337	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.00168	0.0039	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00167	0.00336	CcSEcCtD
Tranexamic Acid—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.00164	0.0033	CcSEcCtD
Tranexamic Acid—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00164	0.00328	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00163	0.00328	CcSEcCtD
Tranexamic Acid—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.00162	0.00325	CcSEcCtD
Tranexamic Acid—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00162	0.00325	CcSEcCtD
Tranexamic Acid—Acute coronary syndrome—Arformoterol—chronic obstructive pulmonary disease	0.00161	0.00322	CcSEcCtD
Tranexamic Acid—Acute coronary syndrome—Formoterol—chronic obstructive pulmonary disease	0.00161	0.00322	CcSEcCtD
Tranexamic Acid—Myocardial infarction—Formoterol—chronic obstructive pulmonary disease	0.0016	0.0032	CcSEcCtD
Tranexamic Acid—Myocardial infarction—Arformoterol—chronic obstructive pulmonary disease	0.0016	0.0032	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—TGFB2—chronic obstructive pulmonary disease	0.00159	0.00369	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—TNF—chronic obstructive pulmonary disease	0.00156	0.00362	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00155	0.0036	CbGpPWpGaD
Tranexamic Acid—Dermatitis atopic—Prednisone—chronic obstructive pulmonary disease	0.00155	0.00311	CcSEcCtD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	0.00153	0.00356	CbGpPWpGaD
Tranexamic Acid—Sinusitis—Formoterol—chronic obstructive pulmonary disease	0.00153	0.00307	CcSEcCtD
Tranexamic Acid—Sinusitis—Arformoterol—chronic obstructive pulmonary disease	0.00153	0.00307	CcSEcCtD
Tranexamic Acid—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.00153	0.00306	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00151	0.00302	CcSEcCtD
Tranexamic Acid—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.0015	0.003	CcSEcCtD
Tranexamic Acid—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00147	0.00295	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.00145	0.00337	CbGpPWpGaD
Tranexamic Acid—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00145	0.00291	CcSEcCtD
Tranexamic Acid—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.00144	0.00289	CcSEcCtD
Tranexamic Acid—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.00141	0.00283	CcSEcCtD
Tranexamic Acid—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.00141	0.00283	CcSEcCtD
Tranexamic Acid—Pulmonary oedema—Prednisolone—chronic obstructive pulmonary disease	0.0014	0.00282	CcSEcCtD
Tranexamic Acid—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.0014	0.00281	CcSEcCtD
Tranexamic Acid—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.00139	0.00278	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.00139	0.00278	CcSEcCtD
Tranexamic Acid—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.00138	0.00277	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.00137	0.00317	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00136	0.00274	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.00136	0.00272	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.00136	0.00272	CcSEcCtD
Tranexamic Acid—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00135	0.00272	CcSEcCtD
Tranexamic Acid—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.00134	0.00269	CcSEcCtD
Tranexamic Acid—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00134	0.00269	CcSEcCtD
Tranexamic Acid—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.00134	0.00269	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—ERBB3—chronic obstructive pulmonary disease	0.00134	0.00311	CbGpPWpGaD
Tranexamic Acid—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00134	0.00269	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.00133	0.00267	CcSEcCtD
Tranexamic Acid—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00132	0.00265	CcSEcCtD
Tranexamic Acid—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00132	0.00265	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00132	0.00264	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00132	0.00264	CcSEcCtD
Tranexamic Acid—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.00262	CcSEcCtD
Tranexamic Acid—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.00131	0.00262	CcSEcCtD
Tranexamic Acid—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.0013	0.00261	CcSEcCtD
Tranexamic Acid—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.00129	0.00259	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00129	0.00259	CcSEcCtD
Tranexamic Acid—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00128	0.00257	CcSEcCtD
Tranexamic Acid—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.00128	0.00257	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.00128	0.00257	CcSEcCtD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—MMP9—chronic obstructive pulmonary disease	0.00128	0.00296	CbGpPWpGaD
Tranexamic Acid—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00127	0.00256	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00126	0.00253	CcSEcCtD
Tranexamic Acid—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00125	0.00251	CcSEcCtD
Tranexamic Acid—PLG—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	0.00125	0.0029	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—TNF—chronic obstructive pulmonary disease	0.00125	0.0029	CbGpPWpGaD
Tranexamic Acid—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00125	0.0025	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.0025	CcSEcCtD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	0.00124	0.00287	CbGpPWpGaD
Tranexamic Acid—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.00247	CcSEcCtD
Tranexamic Acid—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00123	0.00247	CcSEcCtD
Tranexamic Acid—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00123	0.00247	CcSEcCtD
Tranexamic Acid—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.00122	0.00245	CcSEcCtD
Tranexamic Acid—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.00122	0.00245	CcSEcCtD
Tranexamic Acid—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00122	0.00244	CcSEcCtD
Tranexamic Acid—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.00121	0.00242	CcSEcCtD
Tranexamic Acid—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.0012	0.00241	CcSEcCtD
Tranexamic Acid—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.0012	0.0024	CcSEcCtD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	0.00119	0.00276	CbGpPWpGaD
Tranexamic Acid—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.00118	0.00237	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00118	0.00237	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00118	0.00237	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00117	0.00235	CcSEcCtD
Tranexamic Acid—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00233	CcSEcCtD
Tranexamic Acid—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00232	CcSEcCtD
Tranexamic Acid—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00115	0.0023	CcSEcCtD
Tranexamic Acid—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00115	0.0023	CcSEcCtD
Tranexamic Acid—PLG—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	0.00115	0.00266	CbGpPWpGaD
Tranexamic Acid—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00113	0.00227	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00112	0.00224	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.00224	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00111	0.00223	CcSEcCtD
Tranexamic Acid—PLG—Folate Metabolism—TP53—chronic obstructive pulmonary disease	0.0011	0.00255	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	0.00109	0.00253	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.00109	0.00253	CbGpPWpGaD
Tranexamic Acid—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00217	CcSEcCtD
Tranexamic Acid—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00217	CcSEcCtD
Tranexamic Acid—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00217	CcSEcCtD
Tranexamic Acid—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00217	CcSEcCtD
Tranexamic Acid—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00217	CcSEcCtD
Tranexamic Acid—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00217	CcSEcCtD
Tranexamic Acid—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00217	CcSEcCtD
Tranexamic Acid—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00108	0.00217	CcSEcCtD
Tranexamic Acid—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00108	0.00216	CcSEcCtD
Tranexamic Acid—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00215	CcSEcCtD
Tranexamic Acid—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00215	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.00106	0.00247	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—TP53—chronic obstructive pulmonary disease	0.00106	0.00247	CbGpPWpGaD
Tranexamic Acid—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00106	0.00213	CcSEcCtD
Tranexamic Acid—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00106	0.00213	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.00212	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00105	0.00211	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00104	0.00208	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00104	0.00208	CcSEcCtD
Tranexamic Acid—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00205	CcSEcCtD
Tranexamic Acid—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00205	CcSEcCtD
Tranexamic Acid—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00205	CcSEcCtD
Tranexamic Acid—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.00102	0.00205	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00102	0.00204	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.00204	CcSEcCtD
Tranexamic Acid—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00102	0.00204	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00102	0.00204	CcSEcCtD
Tranexamic Acid—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00203	CcSEcCtD
Tranexamic Acid—PLG—Folate Metabolism—IL6—chronic obstructive pulmonary disease	0.00101	0.00234	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00101	0.00202	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000997	0.002	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	0.000992	0.0023	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000981	0.00197	CcSEcCtD
Tranexamic Acid—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00097	0.00195	CcSEcCtD
Tranexamic Acid—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00097	0.00195	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000962	0.00193	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000948	0.0019	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000946	0.0019	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000946	0.0019	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000946	0.0022	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000934	0.00187	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000927	0.00186	CcSEcCtD
Tranexamic Acid—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000926	0.00186	CcSEcCtD
Tranexamic Acid—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000926	0.00186	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP1—chronic obstructive pulmonary disease	0.00092	0.00214	CbGpPWpGaD
Tranexamic Acid—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000916	0.00184	CcSEcCtD
Tranexamic Acid—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000914	0.00183	CcSEcCtD
Tranexamic Acid—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000914	0.00183	CcSEcCtD
Tranexamic Acid—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000902	0.00181	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000897	0.0018	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000897	0.0018	CcSEcCtD
Tranexamic Acid—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000895	0.0018	CcSEcCtD
Tranexamic Acid—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000895	0.0018	CcSEcCtD
Tranexamic Acid—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000895	0.0018	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000893	0.00179	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000878	0.00176	CcSEcCtD
Tranexamic Acid—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000877	0.00176	CcSEcCtD
Tranexamic Acid—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000874	0.00175	CcSEcCtD
Tranexamic Acid—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000869	0.00174	CcSEcCtD
Tranexamic Acid—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000868	0.00174	CcSEcCtD
Tranexamic Acid—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000864	0.00173	CcSEcCtD
Tranexamic Acid—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000863	0.00173	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000856	0.00172	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000856	0.00172	CcSEcCtD
Tranexamic Acid—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000855	0.00172	CcSEcCtD
Tranexamic Acid—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000851	0.00171	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000849	0.0017	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000849	0.0017	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000849	0.00197	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000847	0.0017	CcSEcCtD
Tranexamic Acid—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000845	0.0017	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000832	0.00167	CcSEcCtD
Tranexamic Acid—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000821	0.00165	CcSEcCtD
Tranexamic Acid—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000821	0.00165	CcSEcCtD
Tranexamic Acid—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000818	0.00164	CcSEcCtD
Tranexamic Acid—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00081	0.00163	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000808	0.00162	CcSEcCtD
Tranexamic Acid—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000806	0.00162	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	0.000805	0.00187	CbGpPWpGaD
Tranexamic Acid—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000804	0.00161	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	0.000804	0.00187	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000802	0.00161	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	0.0008	0.00186	CbGpPWpGaD
Tranexamic Acid—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000796	0.0016	CcSEcCtD
Tranexamic Acid—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000792	0.00159	CcSEcCtD
Tranexamic Acid—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000775	0.00156	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000765	0.00178	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000765	0.00154	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000765	0.00154	CcSEcCtD
Tranexamic Acid—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000764	0.00153	CcSEcCtD
Tranexamic Acid—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000763	0.00153	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000749	0.0015	CcSEcCtD
Tranexamic Acid—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000745	0.0015	CcSEcCtD
Tranexamic Acid—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000745	0.0015	CcSEcCtD
Tranexamic Acid—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00073	0.00146	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000722	0.00145	CcSEcCtD
Tranexamic Acid—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00071	0.00143	CcSEcCtD
Tranexamic Acid—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00071	0.00143	CcSEcCtD
Tranexamic Acid—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000707	0.00142	CcSEcCtD
Tranexamic Acid—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000703	0.00141	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—SERPINE1—chronic obstructive pulmonary disease	0.000699	0.00162	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000696	0.0014	CcSEcCtD
Tranexamic Acid—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000687	0.00138	CcSEcCtD
Tranexamic Acid—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000687	0.00138	CcSEcCtD
Tranexamic Acid—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000673	0.00135	CcSEcCtD
Tranexamic Acid—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000671	0.00135	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.00067	0.00156	CbGpPWpGaD
Tranexamic Acid—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00066	0.00132	CcSEcCtD
Tranexamic Acid—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00066	0.00132	CcSEcCtD
Tranexamic Acid—Headache—Formoterol—chronic obstructive pulmonary disease	0.000651	0.00131	CcSEcCtD
Tranexamic Acid—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000651	0.00131	CcSEcCtD
Tranexamic Acid—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000648	0.0013	CcSEcCtD
Tranexamic Acid—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000647	0.0013	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000644	0.00149	CbGpPWpGaD
Tranexamic Acid—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000639	0.00128	CcSEcCtD
Tranexamic Acid—Headache—Montelukast—chronic obstructive pulmonary disease	0.000637	0.00128	CcSEcCtD
Tranexamic Acid—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000632	0.00127	CcSEcCtD
Tranexamic Acid—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000628	0.00126	CcSEcCtD
Tranexamic Acid—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000623	0.00125	CcSEcCtD
Tranexamic Acid—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000621	0.00125	CcSEcCtD
Tranexamic Acid—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000617	0.00124	CcSEcCtD
Tranexamic Acid—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000617	0.00124	CcSEcCtD
Tranexamic Acid—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000614	0.00123	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000606	0.00122	CcSEcCtD
Tranexamic Acid—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000604	0.00121	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000602	0.0014	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000597	0.00139	CbGpPWpGaD
Tranexamic Acid—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000597	0.0012	CcSEcCtD
Tranexamic Acid—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000582	0.00117	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—EGFR—chronic obstructive pulmonary disease	0.000582	0.00135	CbGpPWpGaD
Tranexamic Acid—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00058	0.00116	CcSEcCtD
Tranexamic Acid—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000578	0.00116	CcSEcCtD
Tranexamic Acid—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000575	0.00115	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000562	0.00113	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.000554	0.00129	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000547	0.00127	CbGpPWpGaD
Tranexamic Acid—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000538	0.00108	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000537	0.00125	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP9—chronic obstructive pulmonary disease	0.000535	0.00124	CbGpPWpGaD
Tranexamic Acid—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000534	0.00107	CcSEcCtD
Tranexamic Acid—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000522	0.00105	CcSEcCtD
Tranexamic Acid—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.00052	0.00104	CcSEcCtD
Tranexamic Acid—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000514	0.00103	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.000508	0.00118	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000493	0.00114	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000488	0.00113	CbGpPWpGaD
Tranexamic Acid—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000465	0.000932	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000463	0.00093	CcSEcCtD
Tranexamic Acid—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000463	0.000929	CcSEcCtD
Tranexamic Acid—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000452	0.000906	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—IL6—chronic obstructive pulmonary disease	0.000448	0.00104	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—TGFB1—chronic obstructive pulmonary disease	0.000441	0.00102	CbGpPWpGaD
Tranexamic Acid—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.00044	0.000883	CcSEcCtD
Tranexamic Acid—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000434	0.000871	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	0.00043	0.000998	CbGpPWpGaD
Tranexamic Acid—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000426	0.000855	CcSEcCtD
Tranexamic Acid—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000426	0.000855	CcSEcCtD
Tranexamic Acid—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000421	0.000845	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	0.000416	0.000966	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000415	0.000964	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000414	0.000962	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000414	0.000831	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000409	0.00082	CcSEcCtD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000403	0.000935	CbGpPWpGaD
Tranexamic Acid—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000401	0.000804	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000396	0.00092	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000393	0.000913	CbGpPWpGaD
Tranexamic Acid—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000372	0.000747	CcSEcCtD
Tranexamic Acid—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000372	0.000746	CcSEcCtD
Tranexamic Acid—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.00036	0.000722	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000359	0.000833	CbGpPWpGaD
Tranexamic Acid—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000352	0.000707	CcSEcCtD
Tranexamic Acid—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000352	0.000707	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000341	0.000791	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000337	0.000676	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000334	0.000671	CcSEcCtD
Tranexamic Acid—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000334	0.00067	CcSEcCtD
Tranexamic Acid—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000323	0.000648	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000301	0.000604	CcSEcCtD
Tranexamic Acid—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000293	0.000588	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000288	0.000668	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000286	0.000663	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00028	0.000561	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	0.000277	0.000642	CbGpPWpGaD
Tranexamic Acid—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00027	0.000542	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000267	0.000621	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000262	0.000608	CbGpPWpGaD
Tranexamic Acid—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00026	0.000521	CcSEcCtD
Tranexamic Acid—Headache—Prednisone—chronic obstructive pulmonary disease	0.000256	0.000514	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000247	0.000573	CbGpPWpGaD
Tranexamic Acid—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000243	0.000487	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000221	0.000512	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—TP53—chronic obstructive pulmonary disease	0.000216	0.000501	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000205	0.000475	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.0002	0.000465	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000193	0.000448	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000179	0.000416	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000141	0.000327	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000134	0.000312	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000119	0.000277	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000108	0.00025	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.68e-05	0.000225	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.89e-05	0.000206	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.71e-05	0.000202	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.32e-05	0.00017	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.7e-05	0.000155	CbGpPWpGaD
